Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2
Abstract The impact of repeated sample collection on COVID-19 test performance is unknown. The FDA and CDC currently recommend the primary collection of diagnostic samples to minimize the perceived risk of false-negative findings. We therefore evaluated the association between repeated sample collec...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-94547-0 |
id |
doaj-39dfb0e9ecc74fe6a6c372c4079c88bd |
---|---|
record_format |
Article |
spelling |
doaj-39dfb0e9ecc74fe6a6c372c4079c88bd2021-07-25T11:24:37ZengNature Publishing GroupScientific Reports2045-23222021-07-011111510.1038/s41598-021-94547-0Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2Joshua M. Levy0Jennifer K. Frediani1Erika A. Tyburski2Anna Wood3Janet Figueroa4Russell R. Kempker5Paulina A. Rebolledo6Mark D. Gonzalez7Julie Sullivan8Miriam B. Vos9Jared O’Neal10Greg S. Martin11Wilbur A. Lam12Jesse J. Waggoner13The Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesDepartment of Otolaryngology-Head and Neck Surgery, Emory University School of MedicineThe Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesDepartment of Pediatrics, Emory University School of MedicineDepartment of Pediatrics, Emory University School of MedicineThe Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesThe Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesThe Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesThe Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesThe Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesThe Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesThe Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesThe Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesThe Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesAbstract The impact of repeated sample collection on COVID-19 test performance is unknown. The FDA and CDC currently recommend the primary collection of diagnostic samples to minimize the perceived risk of false-negative findings. We therefore evaluated the association between repeated sample collection and test performance among 325 symptomatic patients undergoing COVID-19 testing in Atlanta, GA. High concordance was found between consecutively collected mid-turbinate samples with both molecular (n = 74, 100% concordance) and antigen-based (n = 147, 97% concordance, kappa = 0.95, CI = 0.88–1.00) diagnostic assays. Repeated sample collection does not decrease COVID-19 test performance, demonstrating that multiple samples can be collected for assay validation and clinical diagnosis.https://doi.org/10.1038/s41598-021-94547-0 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Joshua M. Levy Jennifer K. Frediani Erika A. Tyburski Anna Wood Janet Figueroa Russell R. Kempker Paulina A. Rebolledo Mark D. Gonzalez Julie Sullivan Miriam B. Vos Jared O’Neal Greg S. Martin Wilbur A. Lam Jesse J. Waggoner |
spellingShingle |
Joshua M. Levy Jennifer K. Frediani Erika A. Tyburski Anna Wood Janet Figueroa Russell R. Kempker Paulina A. Rebolledo Mark D. Gonzalez Julie Sullivan Miriam B. Vos Jared O’Neal Greg S. Martin Wilbur A. Lam Jesse J. Waggoner Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2 Scientific Reports |
author_facet |
Joshua M. Levy Jennifer K. Frediani Erika A. Tyburski Anna Wood Janet Figueroa Russell R. Kempker Paulina A. Rebolledo Mark D. Gonzalez Julie Sullivan Miriam B. Vos Jared O’Neal Greg S. Martin Wilbur A. Lam Jesse J. Waggoner |
author_sort |
Joshua M. Levy |
title |
Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2 |
title_short |
Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2 |
title_full |
Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2 |
title_fullStr |
Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2 |
title_full_unstemmed |
Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2 |
title_sort |
impact of repeated nasal sampling on detection and quantification of sars-cov-2 |
publisher |
Nature Publishing Group |
series |
Scientific Reports |
issn |
2045-2322 |
publishDate |
2021-07-01 |
description |
Abstract The impact of repeated sample collection on COVID-19 test performance is unknown. The FDA and CDC currently recommend the primary collection of diagnostic samples to minimize the perceived risk of false-negative findings. We therefore evaluated the association between repeated sample collection and test performance among 325 symptomatic patients undergoing COVID-19 testing in Atlanta, GA. High concordance was found between consecutively collected mid-turbinate samples with both molecular (n = 74, 100% concordance) and antigen-based (n = 147, 97% concordance, kappa = 0.95, CI = 0.88–1.00) diagnostic assays. Repeated sample collection does not decrease COVID-19 test performance, demonstrating that multiple samples can be collected for assay validation and clinical diagnosis. |
url |
https://doi.org/10.1038/s41598-021-94547-0 |
work_keys_str_mv |
AT joshuamlevy impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT jenniferkfrediani impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT erikaatyburski impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT annawood impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT janetfigueroa impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT russellrkempker impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT paulinaarebolledo impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT markdgonzalez impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT juliesullivan impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT miriambvos impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT jaredoneal impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT gregsmartin impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT wilburalam impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 AT jessejwaggoner impactofrepeatednasalsamplingondetectionandquantificationofsarscov2 |
_version_ |
1721283166739628032 |